Condition

Rubeosis Iridis

ClinicalTrials.gov condition label

Clinical trials2

Recruiting0

Common interventions3

Lead sponsors shown1

Clinical trials

2 shown

Intravitreal Aflibercept or Ranibizumab for Rubeosis IridisNCT02641457 · 2014-03-01

COMPLETED

Intraocular Bevacizumab (Avastin) for Rubeosis IridisNCT00557232 · 2006-11-01

COMPLETED

Common interventions

AfliberceptDRUG1bevacizumabDRUG1RanibizumabDRUG1

Leading sponsors

Instituto de Olhos de Goiania2

Trial status mix

COMPLETED2

Phase mix

PHASE31

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.